The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...
Key Takeaways Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration.The drugmaker said the twice-daily pill, Journavx, is the first such treatment to ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...